Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blind Procedures02:07

Blind Procedures

Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which child was...
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Online modulation of neural drive to lower motor neurons with high-definition transcranial alternating current stimulation (HD-tACS).

Journal of neuroengineering and rehabilitation·2026
Same author

Dynamic immune profiling predicts response to radiation plus anti-PD-1 therapy in oligometastatic renal cell carcinoma.

Nature communications·2026
Same author

Effect of [<sup>68</sup>Ga]Ga-PSMA-11 PET-CT in the diagnosis of prostate cancer in men with equivocal or clinically high-risk non-suspicious findings on multiparametric MRI (PRIMARY2): a multicentre, non-inferiority, phase 3, randomised controlled trial.

The Lancet. Oncology·2026
Same author

Cryoneurolysis of auriculotemporal nerve for treatment of otalgia.

BMJ case reports·2026
Same author

Colocalization of Dopamine D1 and D2 Receptors With Neuronal Nitric Oxide Synthase in the Rat Paraventricular Nucleus: A Structural Basis for Dopaminergic-Nitrergic Interaction.

Anatomia, histologia, embryologia·2026
Same author

Long-term outcomes of stereotactic ablative body radiotherapy for primary kidney cancer (TROG 15.03 FASTRACK II): a multicentre, non-randomised, phase 2 study.

The Lancet. Oncology·2026

Related Experiment Video

Updated: Jul 4, 2026

Clinical Assessment of Spatiotemporal Gait Parameters in Patients and Older Adults
08:56

Clinical Assessment of Spatiotemporal Gait Parameters in Patients and Older Adults

Published on: November 7, 2014

13.8K

Management Approaches to Spastic Gait Disorders.

Sheng Li1,2, Tulsi Pandat1,2, Bradley Chi1,2

  • 1Department of Physical Medicine and Rehabilitation, McGovern Medical School, University of Texas Health Science Center - Houston, Houston, Texas, USA.

Muscle & Nerve
|April 8, 2025
PubMed
Summary

Understanding spastic gait involves differentiating spasticity from weakness and considering pelvic and knee abnormalities. Effective management requires individualized, concurrent treatments tailored to patient needs and disease progression.

Keywords:
botulinum toxincerebral palsygaitnerve blockroboticsspasticityspinal cord injurystroketraumatic brain injury

More Related Videos

Sit-to-stand-and-walk from 120% Knee Height: A Novel Approach to Assess Dynamic Postural Control Independent of Lead-limb
08:24

Sit-to-stand-and-walk from 120% Knee Height: A Novel Approach to Assess Dynamic Postural Control Independent of Lead-limb

Published on: August 30, 2016

10.2K
Clinical-oriented Three-dimensional Gait Analysis Method for Evaluating Gait Disorder
06:54

Clinical-oriented Three-dimensional Gait Analysis Method for Evaluating Gait Disorder

Published on: March 4, 2018

14.0K

Related Experiment Videos

Last Updated: Jul 4, 2026

Clinical Assessment of Spatiotemporal Gait Parameters in Patients and Older Adults
08:56

Clinical Assessment of Spatiotemporal Gait Parameters in Patients and Older Adults

Published on: November 7, 2014

13.8K
Sit-to-stand-and-walk from 120% Knee Height: A Novel Approach to Assess Dynamic Postural Control Independent of Lead-limb
08:24

Sit-to-stand-and-walk from 120% Knee Height: A Novel Approach to Assess Dynamic Postural Control Independent of Lead-limb

Published on: August 30, 2016

10.2K
Clinical-oriented Three-dimensional Gait Analysis Method for Evaluating Gait Disorder
06:54

Clinical-oriented Three-dimensional Gait Analysis Method for Evaluating Gait Disorder

Published on: March 4, 2018

14.0K

Area of Science:

  • Neurology
  • Biomechanics
  • Physical Therapy

Background:

  • Spastic gait results from upper motor neuron syndromes and neuromuscular diseases, characterized by spasticity, weakness, and abnormal synergies.
  • Differentiating primary causes like weakness versus spasticity is crucial for understanding gait disorder phenotypes.
  • Pelvic and knee joint abnormalities significantly influence gait presentation and compensatory mechanisms.

Purpose of the Study:

  • To elucidate the complex factors contributing to spastic gait disorders.
  • To emphasize the importance of distinguishing between spasticity and weakness as primary gait impairments.
  • To review current and investigational treatment strategies for spastic gait.

Main Methods:

  • Clinical observation and analysis of spastic gait phenotypes.
  • Diagnostic nerve blocks and instrumented gait analysis for accurate diagnosis.
  • Review of existing and emerging therapeutic interventions.

Main Results:

  • Spastic gait is a multifactorial condition influenced by neurological deficits and biomechanical factors.
  • Pelvic and knee abnormalities play key roles in gait compensation and presentation.
  • A broad range of treatments, from therapeutic exercise to surgical interventions and neuromodulation, are available.

Conclusions:

  • Individualized care plans integrating various concurrent treatments are essential for managing spastic gait.
  • Treatment selection should be based on thorough evaluation, patient input, and goal setting.
  • Regular re-evaluation of treatment effectiveness is critical, especially for progressive diseases like amyotrophic lateral sclerosis.